FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4710311000001105: FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1288041000001113 FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1288051000001111 FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Is a Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches 2 patch true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Is pack of FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has active ingredient Levonorgestrel false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has manufactured dose form Prolonged-release transdermal patch false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has AMP FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has specific active ingredient Levonorgestrel true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start